LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $70 | -97.8% | 206 | -97.1% | 0.00% | – |
| Q4 2022 | $3,235 | -94.2% | 7,188 | -88.8% | 0.00% | – |
| Q3 2022 | $56,000 | -80.0% | 63,937 | -73.7% | 0.00% | – |
| Q2 2022 | $280,000 | -80.8% | 243,483 | -70.9% | 0.00% | – |
| Q1 2022 | $1,462,000 | -46.1% | 835,925 | -0.1% | 0.00% | – |
| Q4 2021 | $2,713,000 | -7.7% | 837,078 | +14.2% | 0.00% | – |
| Q3 2021 | $2,940,000 | +293900.0% | 733,011 | +162791.3% | 0.00% | – |
| Q2 2021 | $1,000 | – | 450 | +476.9% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 78 | -97.4% | 0.00% | – |
| Q2 2020 | $6,000 | – | 3,000 | +1718.2% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 165 | -83.5% | 0.00% | – |
| Q2 2019 | $2,000 | – | 1,000 | +16566.7% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 6 | -97.8% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 273 | -43.7% | 0.00% | – |
| Q4 2017 | $3,000 | -25.0% | 485 | +18.9% | 0.00% | – |
| Q1 2017 | $4,000 | – | 408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
| Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
| CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
| Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
| Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
| DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
| J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
| MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
| 683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |